Abstract

Gold nanohexapods represent a novel class of optically tunable nanostructures consisting of an octahedral core and six arms grown on its vertices. By controlling the length of the arms, their localized surface plasmon resonance peaks could be tuned from the visible to the near-infrared region for deep penetration of light into soft tissues. Herein we compare the <i>in vitro</i> and <i>in vivo</i> capabilities of Au nanohexapods as photothermal transducers for theranostic applications by benchmarking against those of Au nanorods and nanocages. While all these Au nanostructures could absorb and convert near-infrared light into heat, Au nanohexapods exhibited the highest cellular uptake and the lowest cytotoxicity <i>in vitro</i> for both the as-prepared and PEGylated nanostructures. <i>In vivo</i> pharmacokinetic studies showed that the PEGylated Au nanohexapods had significant blood circulation and tumor accumulation in a mouse breast cancer model. Following photothermal treatment, substantial heat was produced <i>in situ</i> and the tumor metabolism was greatly reduced for all these Au nanostructures, as determined with <sup>18</sup>F-flourodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG PET/CT). Combined together, we can conclude that Au nanohexapods are promising candidates for cancer theranostics in terms of both photothermal destruction and contrast-enhanced diagnosis

    Similar works

    Full text

    thumbnail-image

    Available Versions